Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03189212 · ClinicalTrials.gov registry record · NA
Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03189212 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 15 participants.
The verdict
NCT03189212, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a telemedicine follow-up visit at the NYU Langone Transplant Institute is a feasible and acceptable alternative to a traditional in-center follow-up visit.
Interventions
- BEHAVIORAL Usual Care Visit
- BEHAVIORAL Telemedicine Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2021-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03189212
The ClinicalTrials.gov registry entry for NCT03189212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care Visit is the first listed.
NCT03189212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03189212 about?
NCT03189212 is a clinical study titled "Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation". The purpose of this study is to determine whether a telemedicine follow-up visit at the NYU Langone Transplant Institute is a feasible and acceptable alternative to a traditional in-center follow-up visit.
What is the current status of trial NCT03189212?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-10-01. Estimated completion is 2021-01-19.
What interventions are being tested in trial NCT03189212?
The interventions under investigation include: Usual Care Visit (BEHAVIORAL), Telemedicine Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT03189212?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.